Expression of “DNA damage response” pathway genes in diffuse large B‐cell lymphoma: The potential for exploiting synthetic lethality
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of “DNA damage response” pathway genes in diffuse large B‐cell lymphoma: The potential for exploiting synthetic lethality
Authors
Keywords
-
Journal
HEMATOLOGICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-06
DOI
10.1002/hon.3225
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer
- (2023) Dengchuan Wang et al. Frontiers in Genetics
- Prospects of POLD1 in Human Cancers: A Review
- (2023) Michał Gola et al. Cancers
- MYD88L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy
- (2022) Rongrong Chen et al. Therapeutic Advances in Hematology
- A single-cell atlas of diffuse large B cell lymphoma
- (2022) Xiaofei Ye et al. Cell Reports
- Next-generation sequencing identifies potential novel therapeutic targets in Chinese HGSOC patients
- (2022) Junyan Tao et al. PATHOLOGY RESEARCH AND PRACTICE
- Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer
- (2022) Jun-Yan Liu et al. Frontiers in Pharmacology
- Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy
- (2022) Fan Yang et al. Biomolecules
- Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma
- (2022) Anthony R. Colombo et al. Blood Advances
- Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma
- (2022) Yang Li et al. Biomed Research International
- A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer
- (2022) Ling Li et al. Frontiers in Oncology
- 2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management
- (2021) Sandra Susanibar‐Adaniya et al. AMERICAN JOURNAL OF HEMATOLOGY
- Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
- (2021) Andrew N.J. Tutt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
- (2021) Wyndham H. Wilson et al. CANCER CELL
- The Novel Therapeutic Landscape for Relapsed/Refractory Diffuse Large B Cell Lymphoma
- (2021) Sri Nuvvula et al. Clinical Lymphoma Myeloma & Leukemia
- Novel Peptide Therapeutic Approaches for Cancer Treatment
- (2021) Caroline M. Li et al. Cells
- Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases in Colorectal Cancer Patients
- (2020) Pavel Vodicka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors
- (2020) Florent Peyraud et al. Cancers
- GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
- (2019) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas
- (2019) Bernd Kaina et al. DNA REPAIR
- Follicular lymphoma: 2020 update on diagnosis and management
- (2019) Arnold Freedman et al. AMERICAN JOURNAL OF HEMATOLOGY
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs
- (2018) Jan Devan et al. SEMINARS IN ONCOLOGY
- Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
- (2017) Matthew S. Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- Bruton’s tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia
- (2017) J Deng et al. LEUKEMIA
- Synthetic lethality and cancer
- (2017) Nigel J. O'Neil et al. NATURE REVIEWS GENETICS
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Repair Pathway Choices and Consequences at the Double-Strand Break
- (2016) Raphael Ceccaldi et al. TRENDS IN CELL BIOLOGY
- Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
- (2015) Wyndham H Wilson et al. NATURE MEDICINE
- Genetic Variation in DNA Repair Pathways and Risk of Non-Hodgkin's Lymphoma
- (2014) Justin Rendleman et al. PLoS One
- The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib
- (2013) Girija Dasmahapatra et al. BRITISH JOURNAL OF HAEMATOLOGY
- DNA repair genes are selectively mutated in diffuse large B cell lymphomas
- (2013) Noel FCC de Miranda et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
- (2013) Jessica Okosun et al. NATURE GENETICS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Aggressive Lymphomas
- (2010) Georg Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- The consequences of Rad51 overexpression for normal and tumor cells
- (2008) Hannah L. Klein DNA REPAIR
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started